Cagrilintide is a long-acting, synthetic analog of human amylin. Amylin is a peptide hormone co-secreted with insulin by pancreatic beta cells. In laboratory research settings, Cagrilintide is investigated for its ability to activate amylin receptors, which are implicated in the regulation of gastric emptying, glucagon secretion, and satiety signaling.